Gapping down
In reaction to disappointing earnings/guidance:
- FLNT -26%, OGI -21.8%, HBM -11.2%, TDW -6.7%, TSN -6%, UGI -5.9%, IIVI -5%, AAP -4.6%, CVET -4%, EPC -3.7%, EGRX -3.7%, RETA -3.4%, TME -2.8%, FTK -1.1%
Other news:
- SLDB -65.7% (discloses that the FDA has notified the company that the IGNITE DMD Phase I/II study of SGT-001 has been placed on clinical hold)
- RETA -3.4% (announces top-line year one results from Phase 3 portion of CARDINAL study)
- JCOM -0.6% (announces proposed private offering of $500.0 mln aggregate principal amount of convertible senior notes), .
Analyst comments:
- AMRX -4.2% (downgraded to Underweight from Neutral at JP Morgan)
- CSX -1.7% (downgraded to Hold from Buy at Deutsche Bank)
- BOX -1.2% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)